Group characteristics of PD and HC
| Group | HC (n=65) | PD (n=65) | p-value |
|---|---|---|---|
| Age (mean±SD) | 58.7±11.1 | 60.5±9.6 | 0.316 |
| Sex (male/female) | 44/21 | 43/22 | |
| Dominant side (left/right) | 27/38 | ||
| Education years (mean±SD) | 15.5±3.0 | 15.2±3.1 | 0.186 |
| Age onset (years) | 58.4±10.2 | ||
| Duration of disease (months) | 6.4±6.9 | ||
| Total levodopa equivalent daily dose | 547.0±264.0 | ||
| MoCA (mean±SD) | 28.3±1.2 | 27.7±1.8 | 0.509 |
| MDS-UPDRS III Score (mean±SD) | 0.7±1.7 | 19.5±8.9 | <0.001 |
HC, healthy controls; PD, parkinson’s disease; SD, standard deviation; MoCA, Montreal Cognitive Assessment Test Scoring; MDS-UPDRS III, Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale.